"cancer biomarker" trang 3 - tải miễn phí từ tailieunhanh
Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: A prospective cohort study

Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: A prospective cohort study
10    29    1
Biomarkers: Paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma

Biomarkers: Paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma
20    56    1
Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
10    62    1
Regularized logistic regression with network-based pairwise interaction for biomarker identification in breast cancer

Regularized logistic regression with network-based pairwise interaction for biomarker identification in breast cancer
18    37    1
Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia

Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia
11    20    1
LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma

LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
16    4    1
ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas

ARPC5 acts as a potential prognostic biomarker that is associated with cell proliferation, migration and immune infiltrate in gliomas
14    7    1
PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
17    1    1
CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress

CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress
8    91    0
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report

Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report
5    83    0
Interleukin 8 is a biomarker of telomerase inhibition in cancer cells

Interleukin 8 is a biomarker of telomerase inhibition in cancer cells
9    49    1
A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer

A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer
10    61    1
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
10    69    1
Microrna expression in formalin fixed paraffin embedded cancer tissue: Identifying reference micrornas and variability

Microrna expression in formalin fixed paraffin embedded cancer tissue: Identifying reference micrornas and variability
11    33    1
Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
9    52    1
Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy

Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy
7    33    1
Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer
7    34    1
MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
10    84    1
MicroRNA expression as risk biomarker of breast cancer metastasis: A pilot retrospective case-cohort study

MicroRNA expression as risk biomarker of breast cancer metastasis: A pilot retrospective case-cohort study
12    53    1
Osteopontin is a prognostic biomarker in non-small cell lung cancer

Osteopontin is a prognostic biomarker in non-small cell lung cancer
10    69    1